Therapeutic advances of targeting receptor tyrosine kinases in cancer

C Tomuleasa, AB Tigu, R Munteanu… - … and Targeted Therapy, 2024 - nature.com
Receptor tyrosine kinases (RTKs), a category of transmembrane receptors, have gained
significant clinical attention in oncology due to their central role in cancer pathogenesis …

Eph receptor signaling and ephrins

EM Lisabeth, G Falivelli… - Cold Spring Harbor …, 2013 - cshperspectives.cshlp.org
The Eph receptors are the largest of the RTK families. Like other RTKs, they transduce
signals from the cell exterior to the interior through ligand-induced activation of their kinase …

Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma

E Lou, S Fujisawa, A Morozov, A Barlas, Y Romin… - PloS one, 2012 - journals.plos.org
Tunneling nanotubes are long, non-adherent F-actin-based cytoplasmic extensions which
connect proximal or distant cells and facilitate intercellular transfer. The identification of …

Targeting EphA2 in cancer

T **ao, Y **ao, W Wang, YY Tang, Z **ao… - Journal of hematology & …, 2020 - Springer
Eph receptors and the corresponding Eph receptor-interacting (ephrin) ligands jointly
constitute a critical cell signaling network that has multiple functions. The tyrosine kinase …

Oncogenic functions and therapeutic targeting of EphA2 in cancer

K Wilson, E Shiuan, DM Brantley-Sieders - Oncogene, 2021 - nature.com
More than 25 years of research and preclinical validation have defined EphA2 receptor
tyrosine kinase as a promising molecular target for clinical translation in cancer treatment …

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

M Tandon, SV Vemula, SK Mittal - Expert opinion on therapeutic …, 2011 - Taylor & Francis
Importance of the field: High mortality rates with cancers warrant further development of
earlier diagnostics and better treatment strategies. Membrane-bound erythropoietin …

The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation

B Mathew, FE Lennon, J Siegler… - Anesthesia & …, 2011 - journals.lww.com
BACKGROUND: The possibility that μ opioid agonists can influence cancer recurrence is a
subject of recent interest. Epidemiologic studies suggested that there were differences in …

[HTML][HTML] Membrane-type matrix metalloproteases as diverse effectors of cancer progression

SP Turunen, O Tatti-Bugaeva, K Lehti - Biochimica et Biophysica Acta (BBA …, 2017 - Elsevier
Membrane-type matrix metalloproteases (MT-MMP) are pivotal regulators of cell invasion,
growth and survival. Tethered to the cell membranes by a transmembrane domain or GPI …

[HTML][HTML] Genetic changes in squamous cell lung cancer: a review

RS Heist, LV Sequist, JA Engelman - Journal of thoracic oncology, 2012 - Elsevier
Identifying specific somatic mutations that drive tumor growth has transformed the treatment
of lung cancer. For example, cancers with sensitizing epidermal growth factor receptor …

Cortactin in cell migration and cancer at a glance

SM MacGrath, AJ Koleske - Journal of cell science, 2012 - journals.biologists.com
Weaver, 2008). Cortactin was first identified as a prominent substrate of the Src nonreceptor
tyrosine kinase. Its name was derived from the observation that cortactin localizes to cortical …